Inside the Rise of circRNA
July 9, 2026
Circio CEO Erik Wiklund reflects on the discovery of human circular RNA and its evolution into a fast-moving therapeutic modality
11 min read
False
Advertisement
Development & Clinical
This Week's CGT News: First Treg Therapy Approved
July 7, 2026
First Treg-based cell therapy approved, FDA advanced therapy office faces fresh turnover, and preclinical CAR T studies target rare blood cancers and glioblastoma
5 min read
AI Framework Helps Identify New CAR T Target
July 6, 2026
A human-in-the-loop AI strategy helped narrow more than 10,000 candidates to a CAR T target now validated in mouse models
2 min read
Biopharma Vital Signs – Part 3: Pressure Points
July 3, 2026
From clinical translation and regulatory expectations to manufacturing readiness, capital constraints, and commercial viability, experts identify the pressure points shaping the path from discovery to market
13 min read
A Singular Approach to Combatting Infectious Disease
By LaToya Montgomery, Anis Larbi
July 2, 2026
How single-cell analysis is evolving to improve vaccine development
4 min read
CAR T Cells Target TNF in Mouse Model of Rheumatoid Arthritis
June 30, 2026
A single infusion of engineered T cells degraded soluble TNF and produced durable disease control in mice
2 min read
Why Early QC Planning Matters in Cell and Gene Therapy
By Laurent Claisse
June 30, 2026
Late-stage CMC setbacks often begin with early QC decisions that shape cell and gene therapy timelines, costs, and regulatory outcomes
7 min read
Biopharma Vital Signs – Part 2: Emerging Trends
June 26, 2026
Industry experts discuss the trends reshaping biotech and biopharma development – from complex modalities and manufacturing pressures to AI, funding constraints, and the growing need to plan for commercialization earlier
9 min read
Cell & Gene
Development & Clinical
Outsourcing
Regulation & Standards
Business & Trends
Technology & Manufacturing
Roving Reporter Asks: What Are Recent Breakthroughs Telling Us About the CGT Field’s Maturity?
June 25, 2026
IBTV speaks with industry leaders at ARM’s Meeting on the Med 2026 to explore what recent clinical, regulatory, and commercial milestones reveal about the next phase of cell and gene therapy
This Week’s CGT News: Gene Therapy Extends Health Span in Mice
June 23, 2026
A gene therapy preserves organ function and boosts life expectancy in mice, while base editing avoids some CRISPR damage in human embryos, and immune clues emerge for CAR T in glioblastoma
4 min read
